Form 4 for OKLO Oklo Inc.
Accepted 2024-11-21 00:00:00 ET · period of report 2024-11-19 · accession 0001104659-24-121560 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-11-21 | 2024-11-19 | OKLO | Altman Samuel H. | Dir | M - OptEx | — | +581.1K | 3.73M | +18% | — |
| DI | 2024-11-21 | 2024-11-19 | OKLO | Altman Samuel H. | Dir | M - OptEx | — | -581.1K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-19 | M | A | 581,100 | — | 3,732,479 | I By Hydrazine Capital II, L.P. | — | — | (F1) Each earnout right represents a contingent right to receive one share of the Issuer's Class A Common Stock (each, an "Earnout Share") upon the satisfaction of certain price thresholds. On November 19, 2024, the Earnout Shares were converted into Class A Common Stock of the Issuer following the achievement of the Issuer's price thresholds as disclosed in the Merger Agreement. (F2) The Reporting Person has sole voting and investment power over the shares held by Hydrazine Capital II, L.P. and therefore may be deemed to share beneficial ownership over such shares. |
| 2 | Derivative | Earnout Rights | 2024-11-19 | M | D | 581,100 | — | 0 | I By Hydrazine Capital II, L.P. | — · — to — | 581,100 Class A Common Stock | (F1) Each earnout right represents a contingent right to receive one share of the Issuer's Class A Common Stock (each, an "Earnout Share") upon the satisfaction of certain price thresholds. On November 19, 2024, the Earnout Shares were converted into Class A Common Stock of the Issuer following the achievement of the Issuer's price thresholds as disclosed in the Merger Agreement. (F2) The Reporting Person has sole voting and investment power over the shares held by Hydrazine Capital II, L.P. and therefore may be deemed to share beneficial ownership over such shares. |